icon
icon
icon
icon
🏷️$300 Off
🏷️$300 Off

News /

Articles /

TCM Group AS: B2C Sales Surge and EBIT Improvement in Q4 2024

Julian WestMonday, Mar 3, 2025 8:10 pm ET
4min read


TCM Group AS (OCSE:TCM) has reported strong B2C sales and improved earnings in the fourth quarter of 2024, according to the company's earnings call. The Danish furniture manufacturer saw a decline in B2B project sales, but this was partially offset by a solid uplift in B2C sales, which grew by more than 5% year on year. This growth in B2C sales contributed to an overall positive order intake in the quarter, with high-single-digit growth year on year.

The gross margin for TCM Group improved slightly in the quarter, as the positive impacts from the improved sales mix were partially offset by increased production costs related to short-term bottlenecks in parts of the supply chain. Despite this, the adjusted EBIT margin increased to 12.9% in Q4 2024 compared to 9.5% in Q4 2023, driven by the strong performance in B2C sales and improved efficiency.



TCM Group's CEO, Torben Paulin, commented on the results, "Sales in the fourth quarter developed as expected, with declining B2B project sales and a solid uplift in B2C sales. Organically, sales in the quarter declined by 2% year on year to DKK 301 million, as the decline in B2B project sales was only partially recouped through B2C sales growth of more than 5% year on year. Full-year revenue was DKK 1,204 million and therefore at the top end of our financial guidance."

TC Accounts Payable


The company also announced that it expects to take full control of Celebert ApS by acquiring the remaining 55% stake in the company during the second half of 2025. This acquisition is expected to drive revenue growth and increased profitability through ongoing efficiency improvements and integration synergies in AUBO. For 2025, TCM Group expects full-year revenue in the range of DKK 1,250-1,400 million and adjusted EBIT of DKK 90-120 million.



In conclusion, TCM Group's strong B2C sales and improved EBIT margin in Q4 2024 demonstrate the company's resilience and adaptability in the face of challenging B2B market conditions. The acquisition of the remaining stake in Celebert ApS is expected to further drive revenue growth and increased profitability in 2025. Investors should keep a close eye on TCM Group's progress as it continues to execute on its growth strategy.
Comments

Add a public comment...
Post
User avatar and name identifying the post author
JimmyCheess
03/04
TCM's B2C surge is 🚀, but watch supply chain bottlenecks.
0
Reply
User avatar and name identifying the post author
sniper459
03/04
TCM's B2C surge is 🔥, but B2B dip is a bummer. Supply chain bottlenecks might pinch margins. Watching them tighten costs like a hawk.
0
Reply
User avatar and name identifying the post author
ttforum
03/04
EBIT margin jump to 12.9% is solid. Betting on TCM to ride the B2C wave. Any contrarian views?
0
Reply
User avatar and name identifying the post author
AP9384629344432
03/04
TCM's guidance for 2025 looks conservative. Revenue range feels like a safe bet. Anyone think they'll beat the high end?
0
Reply
User avatar and name identifying the post author
Caroline Newton
03/04


I'm not trying to convince anyone or promote anyone but honestly speaking on behalf of Brian Wright an expert in crypto trading I made $24,000 on the 25th of November without any complication using some amount of bitcoin I had in my wallet, I got the information on this app months ago and I decided to put a try with working him Brian and it came out great. You can

reach out to here on Telegram @OfficialBrianwright and WhatsApp +1 (508) 819-7429

0
Reply
User avatar and name identifying the post author
Powerballs
03/04
@Caroline Newton Sure
0
Reply
User avatar and name identifying the post author
RamBamBooey
03/04
TCM's B2C hustle is 🔥, but B2B slump is a headwind. Supply chain bottlenecks are the new norm, right?
0
Reply
User avatar and name identifying the post author
jobsurfer
03/04
Celebert acquisition could be a game-changer. More control means more synergy gains. Long-term hold for me.
0
Reply
User avatar and name identifying the post author
yeahyoubored
03/04
TCM's EBIT margin jump is a bullish signal. Holding long-term.
0
Reply
User avatar and name identifying the post author
NoAd7400
03/04
@yeahyoubored I had TCM in my portfolio but sold early. Regretted it when the EBIT margin improved. FOMO hitting hard now.
0
Reply
User avatar and name identifying the post author
Accomplished-Bill-45
03/04
@yeahyoubored How long you planning to hold TCM? Any specific price target in mind?
0
Reply
User avatar and name identifying the post author
Really_Schruted_It
03/04
5% B2C growth is solid; TCM's resilience impresses me.
0
Reply
User avatar and name identifying the post author
Caroline Newton
03/04
@Really_Schruted_It


I'm not trying to convince anyone or promote anyone but honestly speaking on behalf of Brian Wright an expert in crypto trading I made $24,000 on the 25th of November without any complication using some amount of bitcoin I had in my wallet, I got the information on this app months ago and I decided to put a try with working him Brian and it came out great. You can

reach out to here on Telegram @OfficialBrianwright and WhatsApp +1 (508) 819-7429

0
Reply
User avatar and name identifying the post author
SeriousTsuki
03/04
@Caroline Newton 👍
0
Reply
User avatar and name identifying the post author
WorgenFurry
03/04
B2B dip is a red flag, but Celebert acquisition could boost AUBO. 🤔
0
Reply
User avatar and name identifying the post author
Caroline Newton
03/04
@WorgenFurry


I'm not trying to convince anyone or promote anyone but honestly speaking on behalf of Brian Wright an expert in crypto trading I made $24,000 on the 25th of November without any complication using some amount of bitcoin I had in my wallet, I got the information on this app months ago and I decided to put a try with working him Brian and it came out great. You can

reach out to here on Telegram @OfficialBrianwright and WhatsApp +1 (508) 819-7429

0
Reply
User avatar and name identifying the post author
NoBicDeal
03/04
@Caroline Newton Good.
0
Reply
User avatar and name identifying the post author
rareinvoices
03/04
@WorgenFurry True, B2B dip's a worry, but Celebert could be a winner.
0
Reply
Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.
You Can Understand News Better with AI.
Whats the News impact on stock market?
Its impact is
fork
logo
AInvest
Aime Coplilot
Invest Smarter With AI Power.
Open App